January 3, 2024 — Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce the completion of enrollment in both their STIM-ADHF and STOP-ADHF pilot studies.

January 3, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary care solutions, today announced that it has surpassed 250,000 patients receiving a HeartFlow FFRCT Analysis.

A Top 10 look at DAIC's most-read content in December 2023

Here is a rundown of what you and your colleagues found to be most interesting in the field of diagnostic and interventional cardiology during the month of December.

1. Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat Atrial Fibrillation
The Diagnostic and Interventional Cardiology (DAIC) team wish you a happy, healthy and prosperous New Year!

The Diagnostic and Interventional Cardiology (DAIC) team wish you a happy, healthy and prosperous New Year!

December 29, 2023 — Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System* as a first-line treatment for persistent

December 27, 2023 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, and

December 27, 2023 — Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and 

December 26, 2023 — Globally esteemed cardiologist and researcher, Harlan M. Krumholz, MD, SM, FACC, has been named editor-in-chief of the Journal of the American College of Cardiology, the nation’s leading source of clinical research in the field of cardiovascular medicine and the flagship journal of the American College of Cardiology.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now